本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apogee Therapeutics

73.05
+2.133.00%
盘后73.050.00000.00%16:10 EST
成交量:60.71万
成交额:4,394.22万
市值:50.76亿
市盈率:-17.33
高:73.17
开:70.26
低:69.10
收:70.92
52周最高:84.56
52周最低:26.20
股本:6,948.52万
流通股本:5,245.49万
量比:0.55
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-4.2155
每股收益(LYR):-4.2155
净资产收益率:-31.57%
总资产收益率:-21.11%
市净率:5.62
市盈率(LYR):-17.33

数据加载中...

2026/03/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/10/10

重要事件披露

Form 8-K - Current report
2025/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]